Hedge Funds Are Buying LeMaitre Vascular Inc (LMAT)

Now, key hedge funds have been driving this bullishness. McKinley Capital Management established the most outsized position in LeMaitre Vascular Inc (NASDAQ:LMAT). McKinley Capital Management had $1.2 million invested in the company at the end of the quarter. Neil Chriss’ Hutchin Hill Capital also made a $0.2 million investment in the stock during the quarter.

Let’s now review hedge fund activity in other stocks similar to LeMaitre Vascular Inc (NASDAQ:LMAT). We will take a look at Lipocine Inc (NASDAQ:LPCN), VSE Corporation (NASDAQ:VSEC), Ivy High Income Opportunities Fund (NYSE:IVH), and vTv Therapeutics Inc (NASDAQ:VTVT). This group of stocks’ market caps match LMAT’s market cap.

As you can see these stocks had an average of 7 hedge funds with bullish positions and the average amount invested in these stocks was $18 million. That figure was $19 million in LMAT’s case. Lipocine Inc (NASDAQ:LPCN) is the most popular stock in this table with 11 funds reporting stakes in the company. On the other hand, Ivy High Income Opportunities Fund (NYSE:IVH) is the least popular one with only 4 bullish hedge fund positions. LeMaitre Vascular Inc (NASDAQ:LMAT) registers the same level of interest as Lipocine, which suggests that it may be an interesting investment, but more research is required to make a decision regarding the stock’s profitability.